Found 6 matching trials
A Study of AAV5-hRKp.RPGR for the Treatment of Japanese Participants With X-linked Retinitis Pigmentosa
PHASE3The purpose of the study is to assess the safety and tolerability of bilate...
Status
Active Not Recruiting
Location
National Hospital Organization Tokyo Medical Center
Follow-up Gene Therapy Trial for the Treatment of X-linked Retinitis Pigmentosa Associated With Variants in the RPGR Gene
PHASE3A clinical trial of AAV5-hRKp.RPGR vector for participants with X-linked re...
Status
Active Not Recruiting
Location
Shiley Eye Institute Jacobs Retina Center
Gene Therapy for X-linked Retinitis Pigmentosa (XLRP) - Retinitis Pigmentosa GTPase Regulator (RPGR)
PHASE1Phase 1 of the study is a dose escalation of the subretinal administration ...
Location
Massachusetts Eye and Ear Institute
Long-term Follow-up Gene Therapy Study for RPGR- XLRP
N/AThis is a long-term follow-up study assessing safety of patients for up to ...
Location
Massachusetts Eye and Ear Infirmary
A Follow-on Study for Second-Eye Treatment for Participants Previously Treated With Gene Therapy for X-Linked Retinitis Pigmentosa (XLRP)
PHASE2The purpose of this study is to assess the safety and tolerability of subre...
Status
Active Not Recruiting
Location
Massachusetts Eye and Ear Infirmary
Gene Therapy Trial for the Treatment of X-linked Retinitis Pigmentosa Associated With Variants in the RPGR Gene
PHASE3A clinical trial of AAV5-RPGR vector for participants with X-linked retinit...
Location
Shiley Eye Institute Jacobs Retina Center